ALPPS is considered one of the most monumental advancements in liver surgery over the past decade. This technique has undoubtedly revolutionized the management of patients undergoing extensive hepatic resection with an inadequate future liver remnant (FLR). In the initial development phase of ALPPS, the rapid augmentation of the FLR induced prior to liver resection sparked some debate concerning the safety of this procedure and whether it would enhance the safety margin of subsequent extensive hepatectomies. In the early series of cases documented by Andreas A. Schnitzbauer et al., the surgical mortality rate was 12% [1]. A global registry documented a 40% rate of significant complications (Clavien-Dindo IIIa or above) and a 9% surgical mortality rate [2]. Recognizing the risk factors associated with postoperative complications and death can enhance patient selection processes and improve overall results.